October 17, 2007 - Boston Scientific Corp. will be presenting safety and efficacy data on its TAXUS Express2 and TAXUS Liberte Paclitaxel-Eluting Stent Systems at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, October 20-25, 2007, in order to reinforce the safety of the stent systems.
